Sculptra
Sculptra is a poly-L-lactic acid (PLLA) injectable that stimulates collagen formation. Planning focuses on gradual tissue change rather than immediate fullness. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. The safety of direct under-eye injection and Korean approval for it have therefore not been established, and the treatment area is decided by the doctor at the examination. We check whether fine lines and skin texture that bother you up close are the main concern.
Sculptra is available at QD Clinic in Gangnam, Seoul, Korea.


is this for me
Who it’s for
Even if none of these describes you, we will look again at the consultation.
- Sculptra is not a treatment injected directly under the eyes. The manufacturer's US instructions for use state that injection around the eyes has not been studied, so the surrounding facial volume and the under-eye concern are discussed separately. For thin skin or tear troughs, other options may be more suitable.
Suitability requires an examination. Skin thickness, health and previous procedures may make a different approach more appropriate.
start with your concern
Before you pick a treatment name, start with the cause of your concern.
Even a treatment with the same name takes on a different role and scope depending on your current structure, the change you want, what you have had before and the recovery time you have.
Where you are now, and where we start
The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. The safety of direct under-eye injection and Korean approval for it have therefore not been established, and the treatment area is decided by the doctor at the examination.
the principle
How it works
Sculptra
Under-eye darkness may involve hollows, protruding fat, pigmentation or skin quality. Suitability is judged after checking the product’s approved use, the condition of your eyelids and previous treatments. Whether each product is injected directly under the eyes or used on the surrounding area is decided at the examination.

How it works
What sets it apart
Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters.
Assessing the change
Collagen-stimulating treatments are assessed over weeks to months. How tight the skin feels on the treatment day is not used on its own to judge the effect. Rather than recommending a fixed number of sessions up front, we decide whether and how often to repeat from your skin condition, the specific product instructions and your response to the first treatment. Allow recovery time before an important event.
the qd standard
The same treatment, never the same plan.
Rather than a fashionable name or a fixed package, we weigh the structure found at examination, safety, recovery and the limits within one plan.
- DIAGNOSIS FIRST
Cause before name
We first separate out the tissue and the function behind your concern.
- LESS, PRECISE
Only as much as needed
Rather than an excessive change, we plan the smallest scope with a clear role.
- HONEST LIMIT
The limits, explained too
We explain the change you can expect, the alternatives, individual differences and the risks.
personal plan
From consultation to follow-up, planned as one flow.
Sculptra is a poly-L-lactic acid (PLLA) injectable that stimulates collagen formation. Planning focuses on gradual tissue change rather than immediate fullness. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. The safety of direct under-eye injection and Korean approval for it have therefore not been established, and the treatment area is decided by the doctor at the examination. We check whether fine lines and skin texture that bother you up close are the main concern.

Start with the concern
Sculptra is not a treatment injected directly under the eyes. The manufacturer's US instructions for use state that injection around the eyes has not been studied, so the surrounding facial volume and the under-eye concern are discussed separately. For thin skin or tear troughs, other options may be more suitable.
Understand your product
Its approach differs from immediate filling with HA. PLLA cannot be dissolved with hyaluronidase, so conservative planning matters.
Plan through recovery
Even when an injection site is judged suitable, the gradual change from PLLA has to be waited for. We do not add more at short intervals just because the under-eye area looks hollow right now. Progress in the facial area actually planned and changes in under-eye shadows are checked separately.
What the procedure is like
- Before your consultation, please note your usual swelling and dry eyes, any previous filler or surgery, and the medicines you take. If you have an important event or departure date, we plan recovery time and how follow-up will be checked as well.
- After appropriate comfort measures and cleansing, the doctor treats the agreed areas.
- PLLA is not a material that can be dissolved with an enzyme like HA, and nodules may develop late, so we are especially conservative around the eyes. Persistent lumps or swelling need examination. Massage instructions should be confirmed individually according to the product and the area actually treated.
Appointment length depends on consultation, numbing and treatment extent. Tell us your available time and important plans when booking.
Please read this before treatment
- Avoid strong irritation, overheating and strenuous exercise while the skin settles. Follow your individual instructions for when to resume face washing and makeup.
- Massage and pressure advice differs by product. Follow your clinician’s instructions rather than another product’s routine.
- Small bumps that appear right after injection and go down need to be distinguished from nodules that last a long time or appear later. If a firm lump persists or grows, or comes with pain or redness, seek medical care. Non-HA ingredients such as PDLLA, PLLA, PCL and PDO cannot be dissolved with hyaluronidase the way HA filler can.
Safety & considerations
Possible reactions
- Infection, persistent nodules, unevenness, inflammation or allergic reactions can occur.
- Injections carry rare but serious risks including vascular injury or blockage and tissue damage.
Before treatment
- Tell us about pregnancy or breastfeeding, allergies, immune conditions, medicines, and previous fillers, threads or other procedures.
- Active inflammation or infection at the site needs assessment before treatment is scheduled.
Worsening pain, pale or mottled skin, visual symptoms or breathing difficulty need urgent medical attention. Outcomes and duration vary; a specific result is not guaranteed.
what to expect
What to expect over time
A general guide to how the days and months after treatment usually unfold. Results vary by individual.
Immediately
Initial swelling and fullness are not the final result.
Next steps
Plan any further session only after assessing the response and recovery.
Sessions & results
Even when an injection site is judged suitable, the gradual change from PLLA has to be waited for. We do not add more at short intervals just because the under-eye area looks hollow right now. Progress in the facial area actually planned and changes in under-eye shadows are checked separately.
before consultation
Before you decide, the questions people always ask
After injection treatments, infection, persistent nodules or lumps, asymmetry, inflammation or allergic reactions can occur, and although rare, there are serious risks such as blood vessel injury or occlusion. The PLLA in Sculptra cannot be dissolved with an enzyme like HA, and nodules may develop late, so we are especially conservative around the eyes. Persistent lumps or swelling should be examined, and worsening pain or visual problems need immediate care.
Sculptra is a poly-L-lactic acid (PLLA) injectable that stimulates collagen formation. Planning focuses on gradual tissue change rather than immediate fullness. The manufacturer’s US instructions state that Sculptra injection in the periorbital area has not been studied. The safety of direct under-eye injection and Korean approval for it have therefore not been established, and the treatment area is decided by the doctor at the examination.
Sculptra is not a treatment injected directly under the eyes. The manufacturer's US instructions for use state that injection around the eyes has not been studied, so the surrounding facial volume and the under-eye concern are discussed separately. For thin skin or tear troughs, other options may be more suitable.
Even when an injection site is judged suitable, the gradual change from PLLA has to be waited for. We do not add more at short intervals just because the under-eye area looks hollow right now. Progress in the facial area actually planned and changes in under-eye shadows are checked separately.
PLLA is not a material that can be dissolved with an enzyme like HA, and nodules may develop late, so we are especially conservative around the eyes. Persistent lumps or swelling need examination. Massage instructions should be confirmed individually according to the product and the area actually treated.
Look at the examination and the plan rather than the treatment name. First, what the clinic checks before deciding. Second, whether it explains why it recommends that scope and method, compared with the alternatives. Third, whether it reviews your progress with you when results are expected. Our doctor goes through these three points at consultation before the treatment is decided.
At QD Clinic in Gangnam, Seoul, South Korea. We are at 3F, 502 Gangnam-daero, Gangnam-gu, Seoul (Nonhyeon-dong, Seohee Building), a 4-minute walk from Exit 3 of Nonhyeon or Sinnonhyeon Station. Call +82-2-514-1650 or use the consultation form on this site to book a doctor’s consultation first.






